Image

Global Human Immunodeficiency Virus (HIV) Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Apr 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Human immunodeficiency virus (HIV) Market, By Diagnostics (Antigen/Antibody Test, Antibody Test, Nucleic Acid Tests (NATs), CD4T Cell Count, Viral Load, Drug Resistance, Others), Drugs (protease inhibitors (PIs), multi-class combination drugs, fusion inhibitors (FI), Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Others),  Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Others),  Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), Industry Trends and Forecast to 2029.

Human immunodeficiency virus (HIV) Market

Market Analysis and Insights

Human Immunodeficiency Virus (HIV) is a chronic and potentially fatal disease that can be passed from person to person via blood-to-blood and sexual contact. It is a virus that attacks immune cells called CD-4 cells, leaving the body vulnerable to infections and other diseases. The rising prevalence of HIV disease worldwide has influenced the demand for HIV drugs over the years.

Human immunodeficiency virus (HIV) market is expected to gain market growth at a potential rate of 4.3% in the forecast period of 2020 to 2029 and would reach an estimated value of USD 37,122.43 million by the end of the forecast period. The rising prevalence of HIV–AIDS worldwide, as well as emerging markets, are driving the growth of this market.

Human immunodeficiency virus (HIV) Market Dynamics

Drivers

  • Rising cases of HIV-AIDS

The global HIV market is being driven by an increase in HIV-AIDS cases. Due to an increase in sexually transmitted diseases and genetic disruption of CDT4 cells, which weaken the immune system and increase the risk of developing HIV-AIDS, the global HIV market is expanding.

  • Increasing government support as well as availability of treatment

The availability of the treatment is fuelling the growth of this market. Furthermore, the rising prevalence of HIV, as well as government awareness campaigns among the general public, are expected to drive the global HIV market.

  • Continuous research and development

In the forecast period, increased research activities will create advanced opportunities for the growth of the human immunodeficiency virus (HIV) market.

Furthermore, advancement in medical technology, rising initiatives by public and private organizations to spread awareness and growing government funding are the factors that will expand the Human immunodeficiency virus (HIV) market. Other factors such as increase in the demand for effective therapies and rising adoption rate for early genetic counseling will positively impact the Human immunodeficiency virus (HIV) market's growth rate. Additionally, high disposable income, rising number of cases of seizures and changing lifestyle will result in the expansion of Human immunodeficiency virus (HIV) market. 

Restraints/Challenges

However, the high cost of therapies, combined with a lack of reimbursement policies, will impede the growth of the human immunodeficiency virus (HIV) market during the forecast period. Strict FDA guidelines for the approval of new treatments may stymie the global HIV market's growth.

This Human immunodeficiency virus (HIV) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Human immunodeficiency virus (HIV) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Human immunodeficiency virus (HIV) market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Covid-19 Impact on Human immunodeficiency virus (HIV) Market

COVID-19 lockdowns and other restrictions disrupted HIV testing, resulting in sharp drops in diagnoses and referrals to HIV treatment in many countries around the world. The pandemic has had an impact on the growth of this market by causing drug supplies to be suspended and resumed. Furthermore, decreases in new prescriptions for COVID patients in the United States, Europe, and other regions/countries have dampened global demand for antiretroviral and antibiotic products. Furthermore, suppliers' failure to deliver ARVs (antiretroviral drugs) on time, the shutdown of land and air transportation services, and limited access to health services within countries as a result of the pandemic are expected to have a negative impact on the HIV drugs market in the future.

Recent Development

  • Siemens released a software upgrade for the RAPIDComm Data Management System in March 2014, a solution for centralised management of Siemens' In Vitro Diagnostics analyzers and operators at the point-of-care.
  • Siemens Healthineers invested USD 300 million in its Walpole, Massachusetts facility in December 2016 to manufacture the ADVIA Centaur family of Immunoassay instruments.
  • In June 2016, Roche introduced the Cobas e 801 module, which includes over 100 immunoassays and a wide range of disease diagnostics.
  • Thermo Fisher launched the iBind Flex Western device in May 2015, based on the western blot technique for infection detection.

Global Human immunodeficiency virus (HIV) Market Scope

The Human immunodeficiency virus (HIV) market is segmented on the basis of diagnostics, drugs, and route of administration, end-users, distribution channel and others. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Diagnostics

  • antigen/antibody test
  • antibody test
  • nucleic acid tests (NATS)
  • CD4T cell count
  • viral load
  • drug resistance
  • others

On the basis of diagnostics, HIV market is segmented into antigen/antibody test, antibody test, and nucleic acid tests (NATS), CD4T cell count, viral load, drug resistance and others. 

Drugs

  • protease inhibitors (PIS)
  • multi-class combination drugs
  • fusion inhibitors (FI)
  • nucleoside reverse transcriptase inhibitors (NRTIS)
  • others

On the basis of drugs, HIV market is segmented into protease inhibitors (PIS), multi-class combination drugs, fusion inhibitors (FI), nucleoside reverse transcriptase inhibitors (NRTIS) and others. 

Route of administration

  • oral
  • parenteral
  • others

Route of administration segment of HIV market is segmented into oral, parenteral and others.

End Use

  • hospitals
  • speciality clinics
  • others

On the basis of end-users, HIV market is segmented into hospitals, specialty clinics and others.

Distribution channel

  • hospital pharmacy
  • retail pharmacy
  • others

On the basis of distribution channel, HIV market has also been segmented into hospital pharmacy, retail pharmacy others.

Pipeline Analysis

The pipeline analysis of anticonvulsant drugs includes various pipeline therapies such as LP352, OPC-214870, Ganaxolone, CT-010, Vatiquinone E-2730, XEN496, and NBI 827104. Otsuka Pharmaceutical Co. Ltd, Marinus Pharmaceuticals, Cerebral Therapeutics LLC, PTC Therapeutics, Xenon Pharmaceuticals, Longboard Pharmaceuticals, Eisai, Neurocrine Biosciences and others are the involved in the development of potential drugs for the improvement of treatment of seizures.

Human immunodeficiency virus (HIV) Market Regional Analysis/Insights

The Human immunodeficiency virus (HIV) market is analysed and market size insights and trends are provided by country, diagnostics, drugs, route of administration, end-users, distribution channel and others as referenced above.

The countries covered in the Human immunodeficiency virus (HIV) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market due to increased healthcare and R&D expenditure, patient awareness, and global players on novel technology or formulation of existing drugs. Due to high prevalence cases of HIV-AIDS and a large number of generic drugs, Asia-Pacific is expected to grow at a faster rate in the coming years for the HIV market, whereas Europe is expected to have significant bright growth prospects in the coming years due to increased healthcare spending.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Human immunodeficiency virus (HIV) Market Share Analysis

The Human immunodeficiency virus (HIV) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Human immunodeficiency virus (HIV) market.

Some of the major players operating in the Human immunodeficiency virus (HIV) market are F. Hoffmann-La Roche Ltd, Siemens, Thermo Fisher Scientific, Inc., Bristol-Myers Squibb Company, Quest Diagnostics Incorporated AbbVie Inc., Johnson & Johnson Services Inc., Gilead Sciences, Inc., Merck Sharp & Dohme Corp., ViiV Healthcare Mylan pharmaceuticals Inc., Genentech, Inc.,, among others.

Research Methodology

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The Human Immunodeficiency Virus (HIV) Hepatitis Market is to grow at a CAGR of 4.3% During the Forecast Period of 2022 to 2029.
Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), QIAGEN (Netherlands), Danaher (US), Siemens Healthcare GmbH (Germany), Beckman Coulter, Inc. (US), DiaSorin S.p.A. (Italy), Grifols, S.A. (Spain) are the Major Companies Operating in Human Immunodeficiency Virus (HIV) Hepatitis Market.
The Countries Covered in the Human Immunodeficiency Virus (HIV) Hepatitis Market Report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
The Human Immunodeficiency Virus (HIV) Hepatitis Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.